MapLight Therapeutics, Inc.
Undisclosed program
Resolved
179days ago
Catalyst readout · Jan 9, 2026
What's at stake
A key catalyst for Undisclosed program (its lead indication) is expected Jan 9, 2026.
Primary source
· SEC 8-K
verified 13h ago
“On January 9, 2026, the Company updated its corporate presentation for use in meetings with investors, analysts and others (the "Presentation").”